The Barrett’s Antigen Anterior Gradient-2 Silences the p53 Transcriptional Response to DNA Damage
Authors:
- Ashley L. CraigACAshley L. Craig
- James CottonJCJames Cotton
- Laura LawrieLLLaura Lawrie
- John F. DillonJDJohn F. Dillon
- Pete RossPRPete Ross
- Neil KernohanNKNeil Kernohan
- Ted R. HuppTHTed R. Hupp
Open Access
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 3 (6) , 534-547
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Biomarkers in Barrett's esophagusGastrointestinal Endoscopy Clinics of North America, 2003
- Diagnosis of Esophagogastric TumorsEndoscopy, 2003
- The role of chromosomal instability in tumor initiationProceedings of the National Academy of Sciences, 2002
- DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanismsSeminars in Cancer Biology, 2002
- Small changes in expression affect predisposition to tumorigenesisNature Genetics, 2001
- p53 and Neoplastic Progression in Barrett's EsophagusAmerican Journal of Gastroenterology, 2001
- Molecular Genetic Changes in Metastatic Primary Barrett's Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett's AdenocarcinomaLaboratory Investigation, 2000
- Molecular interactions in the Vogelstein model of colorectal carcinomaThe Journal of Pathology, 2000
- Malignant Progression in Barrett’s Esophagus: Pathology and Molecular Biology2000
- p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survivalMolecular Pathology, 1998